Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1951 to 2000 of 8236 results

  1. Robotic assisted bronchoscopy

    Topic prioritisation

  2. Percutaneous transluminal radiofrequency sympathetic denervation of the renal artery for glycemic control

    Topic prioritisation

  3. Low-level laser therapy (photobiomodulation) for oral neuropathic pain

    Topic prioritisation

  4. Full Endoscopic Spine Surgery

    Topic prioritisation

  5. Transcatheter valve-in-valve implantation for the treatment of Tricuspid valve

    Topic prioritisation

  6. The Extraperitoneal approach to left sided colorectal resections ( EXPERTS) Procedure

    Topic prioritisation

  7. Kinetic Oscillation Stimulation to the nasal cavity for the preventive treatment of adults diagnosed with chronic migraine

    Topic prioritisation

  8. High intensity focused ultrasound ablation for pain caused by bone metastases

    Topic prioritisation

  9. Coronary venous arterialisation in patients with refractory angina

    Topic prioritisation

  10. Bariatric left gastric artery embolisation

    Topic prioritisation

  11. Focused Electrohydraulic Shockwaves for wound healing

    Topic prioritisation

  12. External stimulation of the auricular branch of the vagus nerve

    Topic prioritisation

  13. Central arteriovenous anastomosis for the treatment of patients with uncontrolled hypertension

    Topic prioritisation

  14. Intravenous infusion of mesenchymal stromal cells in patients with severe recalcitrant psoriasis

    Topic prioritisation

  15. Deep Brain Stimulation for Alzheimer

    Topic prioritisation

  16. Laparoscopic lumbar sympathectomy for foot hyperhidrosis

    Topic prioritisation

  17. Transarterial Chemoembolisation for inoperable hepatocellular carcinoma

    Topic prioritisation

  18. Neuromodulation for chronic pelvic pain

    Topic prioritisation

  19. MRI guided transurethral high intensity ultrasound ablation of the prostate

    Topic prioritisation

  20. Percutaneous intraductal radiofrequency ablation for malignant biliary obstruction

    Topic prioritisation

  21. Radiofrequency denervation for OA shoulder pain

    Topic prioritisation

  22. Noninvasive Vagus Nerve Stimulation For reactive airway disease

    Topic prioritisation

  23. Transbronchial lung cryobiopsy

    Topic prioritisation

  24. Vaginal microbiota seeding for neonates

    Topic prioritisation

  25. Mechanical Thrombectomy for PE

    Topic prioritisation

  26. Interventional Correction of Superior Sinus Venosus Defect and Partial Anomalous Pulmonary Venous Drainage

    Awaiting development Reference number: GID-IPG10419 Expected publication date: TBC

  27. Percutaneous insertion of a temporary heart pump for left ventricular haemodynamic support in high-risk percutaneous coronary interventions

    Awaiting development Reference number: GID-IPG10409 Expected publication date: TBC

  28. High resolution anoscopy and laser therapy for intraepithelial neoplasia of the anus in high risk or immunocompromised patients

    Topic prioritisation

  29. Multi-vessel minimal access coronary artery surgery for multi-vessel coronary artery disease

    Topic prioritisation

  30. Percutaneous insertion of a temporary heart pump for left ventricular haemodynamic support in high-risk percutaneous coronary interventions

    Awaiting development Reference number: GID-IPG10418 Expected publication date: TBC

  31. XVIVO hypothermic perfusion of the DCD heart

    Topic prioritisation

  32. Botulinum injection of abdominal wall prior to massive incisional hernia repair

    Topic prioritisation

  33. Mexiletine hydrochloride for treating myotonia in children and adolescents with myotonic disorders [TS ID 11978]

    Topic prioritisation

  34. Apalutamide with gonadotrophin-releasing hormone agonist and radiotherapy for treating high-risk, localised or locally advanced prostate cancer [ID6215]

    In development Reference number: GID-TA11199 Expected publication date: TBC

  35. Iodine (131I)–apamistamab for treating relapsed or refractory acute myeloid leukaemia before an allogeneic haematopoietic stem cell transplant [ID6355]

    In development Reference number: GID-TA11425 Expected publication date: TBC

  36. Bentracimab for reversing the antiplatelet activity of ticagrelor [TSID10550][ID6344]

    Awaiting development Reference number: GID-TA11354 Expected publication date: TBC

  37. Veverimer for treating metabolic acidosis in chronic kidney disease [ID3832]

    Topic prioritisation

  38. Evinacumab for treating homozygous familial hypercholesterolemia in children aged 6 months to 11 [TSID11806]

    Topic prioritisation

  39. Durvalumab with bevacizumab and transarterial chemoembolisation for treating locally advanced hepatocellular carcinoma [ID3944]

    Awaiting development Reference number: GID-TA10911 Expected publication date: TBC

  40. Datopotamab deruxtecan for previously treated hormone receptor-positive HER2-negative unresectable or metastatic breast cancer [ID6348]

    In development Reference number: GID-TA11402 Expected publication date: TBC

  41. Pitolisant for treating narcolepsy in children and young people 6 to 17 years ID6353

    Topic prioritisation

  42. Nemolizumab for treating prurigo nodularis [ID6451]

    In development Reference number: GID-TA11566 Expected publication date: TBC

  43. Baloxavir marboxil for treating and preventing influenza in children 1 to 11 years [ID6554]

    Topic prioritisation

  44. DCVax-L for treating glioblastoma [ID836]

    In development Reference number: GID-TA10143 Expected publication date: TBC

  45. Secukinumab for treating giant cell arteritis in people 50 years and over [TSID12163]

    Awaiting development Reference number: GID-TA11761 Expected publication date: TBC

  46. Benegrastim for treating chemotherapy-induced neutropenia in people with breast cancer [TSID11769]

    Awaiting development Reference number: GID-TA11088 Expected publication date: TBC

  47. Canagliflozin for treating type 2 diabetes in people 10 to 17 years [TSID11888]

    Awaiting development Reference number: GID-TA11377 Expected publication date: TBC